SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies - Concepedia

Concepedia

Publication | Open Access

SB1518, a novel macrocyclic pyrimidine-based JAK2 inhibitor for the treatment of myeloid and lymphoid malignancies

DOI Full Paper Access

195

Citations

26

References

2011

Year

Stefan Hart, K C Goh, Veronica Novotny‐Diermayr, C. Y. Hu, Hannes Hentze, Yuxin Tan, Babita Madan, Chithra Amalini, Yung Kiang Loh, L C Ong,

References

	Year	Citations

Page 1